Clinical Trials Directory

Trials / Completed

CompletedNCT00799227

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will evaluate the safety and efficacy of the intravitreal dexamethasone implant in the study eye of vitrectomized subjects with diabetic macular edema. Subjects will be followed for 26 weeks.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone700 µg Dexamethasone Posterior Segment Drug Delivery System Applicator System at Day 1 in the study eye.

Timeline

Start date
2009-01-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-11-27
Last updated
2019-04-23
Results posted
2014-08-04

Locations

2 sites across 2 countries: United States, Australia

Source: ClinicalTrials.gov record NCT00799227. Inclusion in this directory is not an endorsement.